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Abstract: Gut microbiota composition and functionality are closely linked to host health. In this
study, the fecal microbiota and bifidobacterial communities of 111 healthy volunteers from four
regions of China of varying age profiles (Child, 1–5 years; Young, 18–50 years; Elder, 60–80 years;
Longevity, ≥90 years) were investigated via high-throughput sequencing. Canonical analysis revealed
that the gut microbiota, as well as bifidobacteria profiles of the subjects, clustered according to their
regions and age. Eight genera were shared among all subjects, however, certain genera distributed
differently in subjects grouped by region and age. Faecalibacterium was enriched in samples from
Zhongxiang, unclassified Ruminococcaceae and Christensenellaceae were enriched in the Longevity
group, and Bifidobacterium was enriched in Child. Within Bifidobacterium, B. longum was the most
abundant species in almost all samples except for Child, in which B. pseudocatenulatum was the
most abundant. Additionally, the abundances of B. adolescentis and B. dentium were lower in Child.
In conclusion, our results suggest that geography and age affect the structure of the gut microbiota, as
well as Bifidobacterium composition, and this variation may greatly associate with the metabolic and
immune changes that occur during the process of aging.
Keywords: Chinese subjects; gut microbiota; bifidobacterial community; diversity; region; age
1. Introduction
The human gut microbiota is an extremely complex ecosystem with a biomass of 0.15 kg dry
weight [1] and comprises trillions of microorganisms, which are intricately linked to human physiology
and health [2]. Numerous commensal bacteria co-evolve and interact with the mammalian host during
its lifetime [3]. The gut microbiome plays a significant role in the development and regulation of the
Microorganisms 2020, 8, 1108; doi:10.3390/microorganisms8081108 www.mdpi.com/journal/microorganisms
Microorganisms 2020, 8, 1108 2 of 18
immune system and in the development of gut tissue along with serving a multitude of other functions
including colonization resistance and energy regulation, as examples [4–8]. Thus, disruptions and
imbalances to the gut microbiome are connected to several diseases [9–12]. In recent years, research
has focused on unraveling the composition of the microbiota, such as the National Human Microbiome
Program (HMP) [13], Metagenomics of the Human Intestinal Tract (MetaHIT) [14,15] and many other
projects [16,17]. Understanding the composition and functionality of the gut microbiome in health and
disease offers potential targets for the diagnosis, therapy and prevention of some diseases, as well as
promotion of personalized medicine based on nutrition, microorganisms and drugs.
The gut microbiota in healthy people is influenced by multiple factors, such as age, environment
and diet. The physiological changes to the gastrointestinal tract induced by ageing inevitably influence
the structure and functioning of the gut microbiota. Indeed, the early infant gut microbiota is represented
by low biodiversity which increases rapidly in the first 2–5 years until it resembles that of an adult [18],
the adolescent and adult microbiota is relatively stable while the elderly period is defined by a decline
in microbial diversity [16,19].
Bifidobacterium, one of the dominant bacteria in the human gut microbiota, especially in breast-fed
infants, was first discovered in 1899 by Tissier [20]. Bifdobacteria colonize the large intestine of full-term,
healthy and breast-fed infants during the first weeks owing largely to their capacity to utilize human
milk oligosaccharides in breast milk. Certain Bifidobacterium strains have proven health benefits with
disease alleviating effects [21–24].
With the development of sequencing technologies, culture-independent approaches based on
next-generation sequencing have been widely used as powerful tools to detect the gut microbiota or
bifidobacterial community of individuals [25]. This has been largely based on marker gene metagenomics,
particularly 16S rRNA gene amplicon sequencing, which is widely used for bacterial compositional
analysis. However, the resolvability of 16S rRNA gene sequences is limited and cannot distinguish
closely related bacterial species [26,27]. In view of this, our laboratory has developed a high-throughput
sequencing method for the detection of Bifidobacterium species based on the groEL gene, which can
assess the diversity of bifidobacterial composition to species-level [28]. Using both approaches (16S rRNA
gene sequencing and groEL gene sequencing) in this study, we assessed the influence of geography
and age on the structure of the gut microbiota and composition of Bifidobacterium. In total, we collected
111 fecal samples from four regions in China, which could be divided into four groups according to
age; Child (1–5 years), Young (18–50 years), Elder (60–80 years), and Longevity (≥90 years). By using
the Illumina MiSeq sequencing technology, we uncovered the properties of the gut microbiota and
Bifidobacterium composition in fecal samples of individuals from different regions and of different ages.
2. Materials and Methods
2.1. Subject Recruitment and Fecal Sample Collection
This study was approved by the Ethics Committee of Jiangnan University, China (SYXK 2012-0002,
15 February 2015). All the fecal samples from healthy persons were for public health purposes and
these were the only human materials used in the present study. Written informed consent was obtained
from the participants or their legal guardians. Health questionnaires were conducted before sampling
and no human experiments were involved. The collection of fecal samples had no risk of predictable
harm or discomfort to the participants. A total of 111 volunteers were recruited from four regions in
China with different ages (Table S1), and the identity and age of each volunteer was confirmed via
checking their household registers. None of these volunteers had gastrointestinal tract disorders or
had taken antibiotics for at least three months before sampling. Fresh fecal samples were collected
in the early morning before breakfast in a cooler with ice packs and transferred to the laboratory
within 24 h and stored at −80 ◦C. Samples were grouped according to region and age, respectively;
the number of volunteers from each region was as follows: Zhongxiang (21, 15 male and 6 female),
Bo’ai (37, 15 male and 22 female), Chengmai (32, 22 male and 10 female) and Rugao (21, 6 male and
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15 female); samples were grouped by age: Child (1–5 years), Young (18–50 years), Elder (60–80 years)
and Longevity (≥90 years).
2.2. DNA Extraction, PCR Amplification and High-Throughput Sequencing
The total DNA from fecal samples was extracted using FastDNA Spin Kit for Feces (MP Biomedicals,
Santa Ana, CA, USA) according to the manual. The V4 region of the 16S rRNA gene was amplified
with a universal bacterial primer pair: 520F (5′-AYT GGG YDT AAA GNG-3′) and 802R (5′-TAC NVG
GGT ATC TAA TCC-3′) containing a seven-base barcode, and the PCR amplification procedures were
performed as described previously [29]. The groEL gene was amplified with a Bifidobacterium-specific
primer pair: 308F (5′-TCC GAT TAC GAY CGY GAG AAG CT-3′) and 806R (5′-CSG CYT CGG
TSG TCA GGA ACA G–3′) containing a seven-base barcode, and the PCR amplification procedures
were performed as described previously [28]. The PCR products were purified using QIAquick Gel
Extraction Kit (Qiagen GmbH, Hilden, Germany) and quantified with Qubit™ 4 Fluorometer (Life
Technologies Corporation, Carlsbad, CA, USA). Libraries were prepared with TruSeq Nano DNA LT
Kit (Illumina, San Diego, CA, USA) and sequenced with the Miseq Reagent Kit v3 (600 cycles-PE,
Illumina) on the Illumina MiSeq platform according to manufacturer’s instructions.
2.3. Bioinformatics Analysis
Raw sequences were assembled using SeqPrep (https://github.com/jstjohn/SeqPrep) in a QIIME
package (Quantitative Insights into Microbial Ecology, v1.9.1) with default parameters [30]. Reads
that could not be assembled were discarded. Sequences with a fraction of consecutive high-quality
base calls (phred score > 29) lower than 75%, containing ambiguous bases, or lacking a perfect
match to given barcodes were removed. When a sequence had more than three consecutive low
quality base calls (phred score < 30), it was truncated. A customized script was applied to extract
and merge abundance data at different taxonomic levels. High-quality reads were clustered into
operational taxonomic units (OTUs) for further taxonomic analysis. Representative sequences from
each cluster were aligned with the PyNAST aligner to the Greengenes core set, and then a de novo
taxonomic tree was constructed using FastTree v2.1.3 [31]. The taxonomic abundance of each sample
was calculated with Ribosomal Database Project (RDP) classifier v2.10.2 trained with 16S rRNA
training set No. 14 using a bootstrap cutoff of 50% [32]. Subsequently, a gene copy number adjustment
for 16S rRNA sequences was performed. The 16S rRNA copy number data are provided by rrnDB
website (https://rrndb.umms.med.umich.edu/) [33]. The bifidobacterial community profiles were
carried out as previously described [28]. Chao1, Shannon and Simpson indexes were analyzed to
estimate the alpha diversity, principal coordinates analysis (PCoA) was analyzed to estimate the beta
diversity, and these analyses were performed by QIIME; canonical analysis of principle coordinates
(CAP) and permutational multivariate analysis of variance (PERMANOVA) were performed to
evaluate the difference of gut microbiota structure across the cohorts by R-package vegan [34,35].
Linear discriminant analysis effect size (LEfSe) was used to identify the signature microbes that best
differentiate samples grouped by region or age (Wilcoxon rank–sum test, α < 0.05, log LDA >3) [36].
Phylogenetic Investigation of Communities by Reconstruction of Unobserved States (PICRUSt) was
used to obtain a deeper insight into different pathways, based on Kyoto Encyclopedia of Genes and
Genomes (KEGG) orthology [37].
2.4. Statistical Analysis
Statistical analysis was conducted with SPSS 20.0 and GraphPad Prism 7 software. Shapiro–Wilk
normality test was used to verify the normality of distribution for the values. Independent
Kruskal–Wallis test of one-way ANOVA or Tukey’s test of one-way ANOVA was performed to determine
the significant differences among groups depending on the result of normality test. The results were
expressed as median (minimum, maximum). Significant differences were defined as p < 0.05.
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3. Results
3.1. Alpha-Diversity of Gut Microbiota of Subjects from Different Regions and across Age Groups
In total, 111 volunteers were recruited from four regions in China (Figure 1) with different age
profiles (Table S1). A total of 4,913,866 high-quality 16S rRNA gene sequences were obtained from
all the samples, and the average sequence number was 29,424 for each sample. Microbial diversity
was analyzed through Chao1, Shannon and Simpson indexes (Figure 2), in which the Shannon
index revealed significant differences across samples from different locations and with different
ages (Figure 2b,e). Samples from Bo’ai had a significantly higher Shannon index than those from
Zhongxiang and Rugao, indicating that the diversity of gut microbiota in subjects from Bo’ai was
higher. The Shannon index of Chengmai was similar to that of Bo’ai but higher than that of Zhongxiang
and Rugao, although the difference between Chengmai and Rugao was not significant. The Simpson
index of Bo’ai was also higher than that of Zhongxiang and Rugao. Among samples of different ages,
the Shannon and Simpson indexes of Child were significantly lower than that of others. There was no
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Figure 1. Sampling sites in this study. The four sampling sites are represented by colored triangles on
the map. Red: Bo’ai (Henan Province); Green: Rugao (Jiangsu Province); Black: Zhongxiang (Hubei);
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Figure 2. Alpha-diversity of gut microbiota among different regions and ages. Boxes repres nt the
interquartile range (IQR) between the first and third quartil s, and the li es inside the boxes repres nt
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3.2. Beta-Diversity of Gut Microbiota of Subjects from Different Regions and across Age Groups
Principal coordinates analysis (PCoA) of weighted UniFrac distances was analyzed based on
the relative abundances of OTUs to compare the overall structure of the gut microbiota. The results
of PCoA revealed no obvious separation of samples from different regions or with different ages
(Figure S1), however, the results of the canonical analysis of principal coordinates (CAP) indicated
that the samples from different regions and with different ages separated from each other (Figure 3),
which were confirmed by PERMANOVA test (Tables S2 and S3), suggesting that bacterial compositions
differed within each group.
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3.3. Composition of Gut Microbes of Subjects from Different Regions and Age Profiles
The overall microbiota profiles at phylum level are presented in Figure 4. Eight phyla were
detected with relative abundances of more than 0.1% in all the samples. The dominant phyla were
Firmicutes, Bacteroidetes, Proteobacteria and Actinobacteria, where Firmicutes was the dominant phylum
across all groups. Further, the four phyla accounted for more than 48% of the total microbiota. Samples
from Rugao had higher relative abundances of Actinobacteria and Proteobacteria, but without significant
differences (Figure 4a). However, Actinobacteria differed across the different age groups, whereby the
relative abundance of Actinobacteria in Child was significantly higher than that of individuals in Elder
and Longevity groups (p = 0.012 and 0.004, respectively), but the difference between Child and Young
was not significant (Figure 4b).
At genus level, a total of 407 genera were detected in which eight genera existed in all the samples
composing a genus-level phylogenetic core and accounting for 28.63% of the total microbiota (Figure 5).
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All the core genera belonged to Firmicutes apart from Bacteroides. The results of LEfSe showed that
an unclassified Bacteroidales genus, Faecalibacterium, an unclassified S24-7 genus and Sutterella were
among the top genera that distinguished the samples by region (Figure 6a,c). The relative abundance
of an unclassified Bacteroidales genus in the samples from Rugao was significantly higher than that of
all the other groups and the relative abundance of Faecalibacterium in the subjects from Zhongxiang
was significantly higher than that in the other groups (Figure 7a–d). The results also indicated that
an unclassified Ruminococcaceae genus, an unclassified Christensenellaceae genus, Butyricimonas and
Bifidobacterium were among the top genera that distinguished samples grouped by age (Figure 6b,d).
The relative abundances of an unclassified Ruminococcaceae genus and an unclassified Christensenellaceae
genus in the Longevity group were significantly higher than that in the other groups (Figure 7e,f).
The relative abundance of Butyricimonas in Child was significantly lower than that in the other groups,
while the relative abundance of Bifidobacterium in Child was higher than that in the Young, Elder and
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Figure 6. Linear discriminant analy is effect size (LEfSe) analy is of gut microbiota. (a,b) show the
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Figure 7. The genera that distribute differently in samples grouped by age (a–d) and region (e–h).
The colored lines represent the median of each column. * indicates that the difference is significant.
* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
3.4. Functional Gene Composition of Gut Microbiota Predicted by PICRUSt
PICRUSt analysis was used to predict the potential functions of the gut microbiota metagenomes
based on 16 rRNA equences. Analysis of L vel 3 KEGG function classes revealed that age xerted
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Figure 8. The abundance of several genes among different ages. Boxes represent the interquartile
range (IQR) between the first and third quartiles, and the lines inside the boxes represent the median.
Whiskers denote the lowest and highest values within 1.5× IQR from the first and third quartiles,
respectively. The points represent the values with distance from the median exceeding 1.5× IQR.
* indicates that the difference is significant. * p < 0.05, ** p < 0.01, *** p < 0.001.
3.5. Alpha- and Beta-Diversity Analysis of Bifidobacterium Composition within Gut Microbiota of Subjects
from Different Regions and across Age Groups
The analysis of the Bifidobacterium composition was performed with high-throughput sequencing
based on Bifidobacterium specific primers for the groEL gene. Indexes representing alpha-diversity
showed that bifidobacterial diversities were similar among different groups with the exception of the
Chao1 indexes of the Elder and Longevity groups which were significantly different from each other
(Figure S2). The results of PCoA analysis showed that there was no obvious separation of samples
grouped by region or age (Figure S3). However, canonical analysis of principal coordinates (CAP)
of the sequencing data at OTU level suggested that the composition of Bifidobacteirum was different
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abundances  of  seven  Bifidobacterium  species were more  than  1%,  and  B.  longum was  the most 
abundant species with an average relative abundance of 35.48% among different subjects (Figure S4 
and Figure 10). The relative abundance of B. adolescentis in the subjects from Bo’ai was significantly 
higher  than  that  in  Chengmai  and  Rugao;  the  relative  abundance  of  B.  bifidum  in  Rugao was 
significantly lower than that in the other groups; the relative abundances of B. ruminantium in Bo’ai 
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3.6. Composition of Bifidobacterium in Subjects from Different Regions and Age Groups
A total of eleven species of Bifidobacterium were identified in all samples, in which the relative
abundances of seven Bifidobacterium species were more than 1%, and B. longum was the most abundant
species with an average relative abundance of 35.48% among different subjects (Figure S4 and Figure 11).
The relative abundance of B. adolescentis in the subjects from Bo’ai was significantly higher than that in
Chengmai and Rugao; the relative abundance of B. bifidum in Rugao was significantly lower than that in
the other groups; the relative abundances of B. ruminantium in Bo’ai and Zhongxiang were significantly
higher than that in Chengmai and Rugao. Additionally, the relative abundance of B. breve in Chengmai
was significantly lower than other groups. When focusing on the samples by age, Child had a higher
relative abundance of B. pseudocatenulatum than all the other groups, although the difference was not
significant, additionally, Child had significantly lower B. dentium than the other groups. By contrast, the
relative abundance of B. adolescentis in Child was significantly higher than that in Young, and B. breve
exhibited a significant difference between Child and Longevity, in which the former had a significantly
higher abundance.
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4. Discussion
Various studies have uncovered the effects of several factors (such as age, geography and diet)
on the gut microbiota of individuals through high-throughput sequencing. However, few studies
have used the same technique to analyze the composition of Bifidobacterium in the human gut. Indeed,
the composition of Bifidobacterium in gut samples has been detected by cultural methods, fluorescence
in situ hybridization (FISH), qPCR and denaturing gradient gel electrophoresis (DGGE), which are not
appropriate for the analysis of complex samples (such as fecal) and have low resolution power [38–41].
Therefore, in this study, we analyzed the gut microbiota as well as the composition of Bifidobacterium in
people from different regions in China (Figure 1) and of different ages (1–5 years, Child; 18–50 years,
Young; 60–80 years, Elder; ≥90 years, Longevity), using high-throughput sequencing based on the 16S
rRNA gene and the Bifidobacterium-specific groEL gene.
Alpha-diversity (also called within-habitat diversity) presents the species diversity in an area or
habitat and reflects the diversity of the composition of microorganisms and is commonly expressed by
the Shannon–Wiener index, Simpson index and Chao1 index. Interestingly, the Chao1 index did not
differ significantly between the samples grouped by region or age, which indicates that the abundance
of microbiota in subjects from different regions or of different ages was similar. The Shannon and
Simpson indexes indicated that samples from Bo’ai were rich in microbial species and the distribution of
microbes was more uniform compared with samples from Zhongxiang and Rugao. This may be due to
the different dietary structure, in which people in Bo’ai predominantly eat wheaten food and vegetables
while less meat-based food and fat are consumed. A low-fat diet was reported to associate with
higher α-diversity of gut microbiota [42]. The current results revealed that the Shannon and Simpson
indexes in Child were significantly lower than that observed in the other groups. Age and geography
are known to affect the diversity of the gut microbiota. With regards age, it is generally accepted
that the gut microbiota of newborns is acquired from birth onwards where its initial composition is
relatively simple but increases in diversity up to 2–5 years of age until it more closely resembles that of
adults [43–46]. Thus the results of our study are in agreement with those of others, in that the microbiota
of children is less diverse than that of adults. In terms of geography, analysis of the gut microbiota
of healthy children and adults from the Amazonas of Venezuela, rural Malawi and US metropolitan
area showed that the abundance of gut bacteria in Americans was significantly lower than that of the
other groups [16]. Likewise, canonical analysis showed that samples grouped by region or age were
separated from each other, indicating that differences existed in the gut microbiota composition of the
different groups. Other factors besides age and geography also impact gut microbiota composition
including dietary habits and diseases [47–49].
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Human gut microbiota mostly consists of obligate anaerobes, in which members of Firmicutes,
Bacteroidetes, Proteobacteria and Actinobacteria constitute most of the gut microbes [44]. The results in
the current study are in line with those of other studies, in that the four dominant phyla accounted
for 66.60%, 21.64%, 5.56% and 2.66%, respectively. At the genus level, the eight core genera occupied
28.63% of the whole sequence and the majority of the genera in this core were Firmicutes, excluding
Bacteroides (Bacteroidetes phylum). Research on different populations has shown that the human gut
microbiota is mainly composed of several genera of Firmicutes and Bacteroidetes [50]. The most abundant
genera in western and Korean subjects were Bacteroides and Faecalibacterium (Firmicutes), respectively,
while Phascolarctobacterium (Firmicutes) was the most abundant in Chinese subjects [50–52]. However,
in this study, the most abundant genus was Bacteroides followed by Faecalibacterium. This may be due
to the fact that the samples in this study were collected from individuals of Han ethnicity which is the
main group in China and does not represent the gut microbiota characterizatics for all the Chinese
populations, and a previous study found that the relative abundance of many genera (including
Bacteroides and Phascolarctobacterium) were significantly different among ethnic groups [50]. In addition,
Bacteroides is positively related with animal protein in the diet, a variety of amino acids and saturated
fats, hence, high abundance of Bacteroides in the cohort in this study may be associated with a diet rich
in animal products [53]. Furthermore, these results confirm that the structure of the gut microbiota is
extremely complex and affected by many factors, and it is diverse and individual-specific at genus level.
Gut microbiota composition in the samples from different regions showed that the abundance
of Faecalibacterium in Zhongxiang was significantly higher than that in other samples. Many studies
suggest that Faecalibacterium is involved in immuno-regulation. For example, Faecalibacterium prausnitzii
has been consistently reported as one of the major butyrate producers in the intestine, which could
reduce intestinal mucosal inflammation via upregulating PPARγ and inhibiting NF-κB transcription
factor activation and interferon gamma (IFN-γ) [54–57]. Some studies have reported that certain
supplemental fermentable fibers in the diet, such as potato fiber, can increase the abundance of
Faecalibacterium and fecal short chain fatty acid (SCFA) concentrations [58]. The higher abundance of
Faecalibacterium in samples from Zhongxiang may be due to the specific dietary pattern of this region,
which may contain fermentable fibers promoting the proliferation of Faecalibacterium, though this
needs further investigation.
Ageing is defined as “the regression of physiological function accompanied by the development
of age”, and the ageing process seriously impacts human gut microbiota profiles [59]. In our study,
the relative abundances of Ruminococcaceae and Christensenellaceae were significantly higher in Longevity
compared with all other groups, and the abundance of Butyricimonas in Longevity was higher than that
in Child and Elder groups. A study profiling the gut microbiota of long-living individuals from Sichuan,
China and Italy also showed that OTUs of Ruminococcaceae and Christensenellaceae were enriched in
this age group suggesting that these microorganisms may be beneficial [60]. A higher abundance of
Ruminococcaceae was observed in subjects supplemented with resistant starch and Ruminococcaceae is a
well-known butyrate-producer [61,62]. Christensenellaceae has been associated with lean body mass
index (BMI), indeed, supplementation of Christensenella can treat or prevent weight gain, inhibit fat
accumulation, reduce excess adiposity and high BMI, and treat or prevent conditions associated with
adiposity, such as insulin resistance, metabolic syndrome and diabetes [63,64]. Interestingly, during
the recruitment process of this study, almost each longevity volunteer could be described as having
a lean body. Previous studies have indicated that increased body size is associated with reducing
potential longevity [65]. In the current work, the abundance of Butyricimonas in Longevity subjects
was significantly higher than that in the Elder group. The increased abundance of Butyricimonas has
been reported to relate to improved metabolic parameters (including insulin resistance) in mice treated
with metformin, which was associated with the downregulation of pro-inflammatory cytokine IL-6 in
epididymal fat, and IL-6 levels in adipose tissue reportedly increased with age and attenuated insulin
signaling in adipocytes [66–69]. Ageing is generally accompanied by a chronic low-grade inflammation
state (“inflamm-ageing”) which may be linked to the pathogenesis of some chronic diseases, such as
Microorganisms 2020, 8, 1108 13 of 18
cardiovascular disease (CVD) and insulin resistance [70]. Long-living people, especially centenarians,
seem to deal with chronic inflammation via anti-inflammatory responses which could be modulated
by gut microbes, and this may explain the higher abundance of Butyricimonas (butyrate producers with
anti-inflammatory effects) in longevities [71,72].
PICRUSt is a computational approach which predicts the functional composition of genes basing
on 16S rRNA genes and a reference genome database. In our study, the predicted functional gene
compositions were different among groups with different ages. However, our results also showed
that functional gene compositions were homogeneous among different region-groups, which was
not correlated with the different structure of gut microbiota. Microbial communities often exhibit
incredible taxonomic diversity across space, however, this taxonomic diversity may have little effect
on the function, because many coexisting but taxonomically distinct microorganisms can encode
genes with similar functions (functional redundancy in microbial systems), which could explain the
homogeneous compositions of functional genes among different region-groups [73].
Bifidobacterium is the most abundant genus in the gut of vaginally-delivered infants after the
depletion of oxygen by facultative anaerobes [74], in which B. breve, B. bifidum and B. longum subsp.
infantis are most prevalent [26,75–77]. During adulthood, the abundance of bifidobacteial populations
decreases to a relatively stable level which decreases again in old age [78]. In this study, the level
of Bifidobacterium in Child was significantly higher than that in the Elder and Longevity groups
(p < 0.01). Even though there was no significant difference between the Child and Young groups, the
former still had a higher abundance of Bifidobacterium. The predominant bifidobacteria in adults are
B. longum subsp. longum, B. adolescentis and B. catenulatum, and their compositions and abundances in
adults are relatively stable [79]. In elderly populations, the abundance and diversity of bifidobacteria
significantly decrease and their main bifidobacteria are B. adolescentis, B. longum subsp. longum and
B. angulatum [80–82]. Our current results showed that B. longum was the most abundant species in
all groups, except Child in which B. pseudocatenulatum was most abundant and higher than that in
adults even though the difference was not significant, though approached it (p = 0.052). A study
performed by Wu et al. reported that B. pseudocatenulatum was the most dominant Bifidobacterium
species after dietary intervention with non-digestible but fermentable carbohydrates in a genetically
obese child, which suggests that B. pseudocatenulatum can be a particular beneficial bacterium given
the improvement in bioclinical parameters and weight loss in the study subject [83]. Our results also
showed that the relative abundance of B. dentium in Child was significantly lower than that in Young.
B. dentium is usually found in human dental plaque which mostly occurs in adults, thus the lower
levels of B. dentium in Child may be due to this reason [84]. The relative abundance of B. adolescentis in
Child was significantly lower than that in Young. Previous studies have shown that B. adolescentis is
commonly found in adults, and formula-fed babies [85]. In addition, our results indicate that the level
of B. adolescentis in Chengmai was significantly lower than that in Bo’ai and Zhongxiang, which may
be associated with different dietary habits. Indeed, Chengmai is a coastal city where subjects consume
diets rich in sea food while the latter two are inland cities where diets contain more starchy foods.
A genomic and transcriptomic study of B. adolescentis strains revealed a nutrient acquisition strategy
targeting starch and starch-like carbohydrates [86], which could explain the different abundances of
B. adolescentis among volunteers from different regions in this study.
5. Conclusions
In summary, by high-throughput sequencing, we analyzed the gut microbiota and Bifidobacterium
composition of volunteers living in four regions in China with different ages. The results indicate
that eight genera are shared by all the samples, but there were also genera that distributed differently
in samples grouped by region and age. Faecalibacterium was enriched in samples from Zhongxiang;
Ruminococcaceae and Christensenellaceae were enriched in the Longevity group; Bifidobacterium was
enriched in the Child group. The detection of Bifidobacterium indicated that B. longum was the most
abundant Bifidobacterium in almost all samples except for Child, in which B. pseudocatenulatum was
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most abundant. In addition, the results show that the abundance of B. adolescentis and B. dentium
were lower in Child. Further studies are needed to investigate if causal relationships exist between
the varying microbes and certain populations, and how these gut microorganisms interact with each
other and with their host, and how they affect health and the aging process, as well as the intrinsic
mechanisms involved.
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